The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: A case-control study

Human and Experimental Toxicology

Volumn 31, Issue 10, 2012, Pages 1074-1080

  Atinkaya, Cansel ^a   Taspinar, Mehmet ^b   Sakiragaoglu, Onur ^b   Oz, Gurhan ^c   Yazici, Ulku ^c   Oztuna, Derya ^b   Tastepe, Irfan ^c   Sunguroglu, Asuman ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CYP1A1; GSTM1; GSTT1; lung cancer

Indexed keywords

CYTOCHROME P450 1A1; GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 CYP1A1; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; TURKEY;

EID: 84867503455     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111428630     Document Type: Article

References (43)

1. Reszka E, Wasowicz W, Gromadzinska J. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br J Nutr. 2006 ; 96: 609-619
2. Miller YE, Fain P. Genetic susceptibility to lung cancer. Semin Respir Crit Care Med. 2003 ; 24: 197-204
3. Song N, Tan W, Xing D, Lin D. CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in china. Carcinogenesis. 2001 ; 22: 11-16
4. Sørensen M, Autrup H, Tjønneland A, Overvad K, Raaschou-Nielsen O.. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett. 2005 ; 221: 185-190
5. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but non squamous cell carcinoma of the lung. Carcinogenesis. 2006 ; 27: 525-532
6. Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer. 2007 ; 57: 135-42
7. Kihara M, Kihara M, Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis. 1995 ; 16: 2331-2336
8. Oztürk O, Isbir T, Yaylim I, Kocatürk CI, Gürses A. GST M1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas. In Vivo. 2003 ; 17: 625-632
9. Altinisik J, Balta ZB, Aydin G, Ulutin T, Buyru N. Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer. Mol Biol Rep. 2010 ; 37: 263-267
10. Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, Wilkens LR, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Canc Epidemiol Biomarkers Prev. 2000 ; 9: 1119-1122
11. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem. 2004 ; 266: 1-9
12. Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, et al. Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. Biomarkers. 2008 ; 13: 282-295
13. Sambrook J, Fritsch EF, Maniatis T Molecular clonning a laboratory manual. 2 nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Lobisiçanory Press, 1982. Cold Spring Harbor, NY: Cold Spring Harbor Lobisiçanory Press ; 1982 :
14. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnet D. Susceptibility to childhood acute lymphoblastic leukaemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood. 1999 ; 5: 1496-1501
15. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lympho-blastic leukaemia. Environ Mol Mutagen. 2004 ; 43: 100-109
16. Yang XR, Wacholder S, Xu Z, Dean M, Clark V, Gold B, et al. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in chinese women. Cancer Lett. 2004 ; 214: 197-204
17. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but non squamous cell carcinoma of the lung. Carcinogenesis. 2006 ; 27: 525-532
18. Honma HN, Capitani EM, Barberio AS, Costa DB, Morchillo A, Zambon L. Polymorphism of the CYP1A1*2A gene and susceptibility to lung cancer in Brazilian population. J Bras Pneumol. 2009 ; 35: 767-772
19. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR. CYP1A1 and CYP1B1 olymorphisms and risk of lung cancer among. Carcinogenesis. 2005 ; 26: 2207-2212
20. Gallegos-Arreola MP, Figuera-Villanueva LE, Troyo-Sanroman R, Morgán-Villela G, Puebla-Pérez AM, Flores-Marquez MR, et al. CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in mexican patients. Int J Biol Markers. 2008 ; 23: 24-30
21. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res. 2008 ; 639: 1-10
22. Hung RJ, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a poled analysis. Carcinogenesis. 2003 ; 24: 875-882
23. Ng DPK, Tan KW, Zhao B, Seow A. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Canc Causes Contr. 2005 ; 16: 399-405
24. Kumar M, Agarwal SK, Goel SK. Lung cancer risk in north Indian population: role of the genetic polymorphisms and smoking. Mol Cell Biochem. 2009 ; 322: 73-79
25. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 1990 ; 263: 131-133
26. Larsen JE, Colosimo ML, Yang IA, Bowman R, Zimmerman PV, Fong KM. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462val polymorphism. Canc Causes Contr. 2005 ; 16: 579-585
27. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, Kiyohara C, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev. 2008 ; 17: 1120-1126
28. Butkiewicz D, Cole KJ, Phillips DH, Harris CC, Chorazy M.. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J Cancer Prev. 1999 ; 8: 315-323
29. Yoon KA, Kim JH, Gil HJ, Hwang H, Hwangbo B, Lee JS. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women. Lung Cancer. 2008 ; 60: 40-46
30. Cascorbi I, Brockmiller J, Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996 ; 56: 4965-4969
31. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res. 1991 ; 19: 4797
32. Rotunno M, Yu K, Lubin JH, Consonni D, Pesatori AC, Goldstein AM, et al. Phase I metabolic genes and risk of lung cancer multiple polymorphisms and mRNA expression. PloS One. 2009 ; 4: 1-13
33. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 2005 ; 26: 2207-2212
34. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung cancer. 2008 ; 59: 155-63
35. Aynacioglu AS, Cascorbi I, Mrozikiewicz PM, Roots I. High frequency of CYP1A1 mutations in a Turkish population. Arch Toxicol. 1998 ; 72: 215-218
36. Berkman CC, Dinc H, Sekeryapan C, Togan I. Alu insertion polymorphisms and an assessment of the genetic contribution of Central Asia to Anatolia with respect to the Balkans. Am J Phys Anthropol. 2008 ; 136: 11-18
37. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R.. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a south Indian population. J Hum Genet. 2005 ; 50: 618-627
38. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione S-Transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med. 2006 ; 3: 524-534
39. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol. 2008 ; 167: 759-774
40. Pinarbasi H, Silig Y, Cetinkaya O, Seyfikli Z, Pinarbasi E. Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genet Cytogenet. 2003 ; 146: 125-129
41. Ada AO, C Kunak S, Hancer F, Bilgen S, Suzen SH, Alpar S, et al. CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma. 2010 ; 57: 512-521
42. Gonlugur U, Pinarbasi H, Gonlugur TE, Silig Y. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome. Cancer Invest. 2006 ; 24: 497-501
43. Demir A, Altin S, Demir I, Köksal V, Cetinçelik U, Dinçer I. The role of CYP1A1 Msp1 gene polymorphisms on lung cancer development in Turkey. Tuberk Toraks. 2005 ; 53: 5-9